Envista (NYSE:NVST) Updates FY 2026 Earnings Guidance

Envista (NYSE:NVST) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.350-1.450 for the period, compared to the consensus earnings per share estimate of 1.410. The company issued revenue guidance of -.

Envista Stock Down 0.8%

Shares of NVST traded down $0.20 during mid-day trading on Friday, reaching $24.10. The company had a trading volume of 2,519,104 shares, compared to its average volume of 2,847,679. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38. The firm has a 50-day moving average price of $26.53 and a 200 day moving average price of $24.06. Envista has a 52 week low of $16.41 and a 52 week high of $30.42. The company has a market capitalization of $3.93 billion, a price-to-earnings ratio of 58.78, a price-to-earnings-growth ratio of 1.85 and a beta of 0.92.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. The business had revenue of $705.50 million for the quarter, compared to analysts’ expectations of $680.04 million. Envista had a return on equity of 7.09% and a net margin of 2.41%.The firm’s quarterly revenue was up 14.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, sell-side analysts forecast that Envista will post 1.4 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. upped their price objective on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research report on Thursday. UBS Group upped their price objective on Envista from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday, February 3rd. Weiss Ratings raised Envista from a “sell (d)” rating to a “hold (c-)” rating in a research report on Tuesday, February 17th. Stifel Nicolaus set a $31.00 price target on Envista in a report on Friday, February 6th. Finally, Piper Sandler reissued a “neutral” rating and set a $25.00 price target (up from $21.00) on shares of Envista in a report on Friday, February 6th. Six analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $28.83.

Insider Transactions at Envista

In other Envista news, SVP Mischa Reis sold 9,675 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the completion of the sale, the senior vice president owned 32,382 shares in the company, valued at approximately $971,460. This represents a 23.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.99% of the company’s stock.

Institutional Trading of Envista

Several hedge funds have recently modified their holdings of NVST. Caitong International Asset Management Co. Ltd raised its holdings in shares of Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after acquiring an additional 1,504 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares during the last quarter. UMB Bank n.a. increased its stake in Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after acquiring an additional 636 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in Envista by 378.0% during the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after acquiring an additional 1,909 shares during the last quarter. Finally, Quarry LP bought a new stake in Envista during the third quarter worth approximately $66,000.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.